Abstract

Objective: Structural and functional abnormalities have been noted in the prefrontal cortex of individuals with neurodevelopmental disorders such as attention deficit/hyperactivity disorder (ADHD). Cortical thickness and gyrification, both of which have been reported as abnormal in the prefrontal cortex in ADHD, are thought to be modulated by genetic influences during neural development. This study aimed to investigate the effects of a polymorphism of the dopamine DRD4 gene (the 7-repeat (7R) “risk” allele) on thickness and gyrification as distinct parameters of prefrontal cortical structure in children with ADHD. Method: Structural images and genetic samples were obtained from 49 children aged 9–15 years (25 with ADHD and 24 matched controls), and measures of cortical thickness and gyrification for inferior, middle, and superior frontal cortex were calculated. Results: A significant interaction between diagnosis and genotype on prefrontal gyrification was observed, largely driven by reduced inferior frontal gyrification in patients who carried the DRD4 7R allele. Furthermore, inferior frontal gyrification—but not thickness—related to everyday executive functioning in 7R allele carriers across groups. Conclusions: Prefrontal gyrification is reduced in children with ADHD who also carry the DRD4 7R allele, and it relates to critical functional skills in the executive domain in carriers of the risk allele. More broadly, these effects highlight the importance of considering precise neurodevelopmental mechanisms through which risk alleles influence cortical neurogenesis and migration.

Highlights

  • Attention deficit/hyperactivity disorder (ADHD) is a heterogeneous neuropsychiatric disorder characterized by developmentally inappropriate symptoms of inattention, impulsivity, and hyperactivity

  • We investigated the effect of the DRD4 7R allele carrier status on both thickness and gyrification of the lateral prefrontal cortex (PFC) in children with ADHD and healthy controls

  • Participant Characteristics: There were no significant difference in age, gender, or parental socioeconomic status (SES) between children with ADHD and controls

Read more

Summary

Introduction

Attention deficit/hyperactivity disorder (ADHD) is a heterogeneous neuropsychiatric disorder characterized by developmentally inappropriate symptoms of inattention, impulsivity, and hyperactivity. Prefrontal Gyrification in ADHD of genome-wide association studies (GWAS) [e.g., Refs. An abnormality in dopaminergic neurotransmission is well established in ADHD [12, 13] in keeping with the therapeutic effects of methylphenidate (MPH), an indirect dopamine agonist widely used to treat the disorder. ADHD has a strong neurodevelopmental basis, with numerous local and global brain abnormalities being observed [14] in the cortical thickness of the prefrontal regions [15, 16]. Despite the convergence of evidence from genetic and pharmacological studies implicating the dopaminergic system, the relationship between genetic risk factors, dopaminergic imbalances, and the neurodevelopmental abnormalities observed in ADHD is most likely complex and remains unclear, but can be informed by models of genetic influences on cortical development [17, 18]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call